Items where authors include "Reichardt, P"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 5.

Article

Pantaleo, MA, Heinrich, MC, Italiano, A et al. (11 more authors) (2022) A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor. BMC Cancer, 22 (1). 511. 511-. ISSN 1471-2407

Schöffski, P, Wozniak, A, Stacchiotti, S et al. (20 more authors) (2019) Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’. Annals of Oncology, 30 (2). p. 344. ISSN 0923-7534

Schöffski, P, Wozniak, A, Kasper, B et al. (23 more authors) (2018) Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 ‘CREATE’. Annals of Oncology, 29 (3). pp. 758-765. ISSN 0923-7534

Schöffski, P, Wozniak, A, Stacchiotti, S et al. (20 more authors) (2017) Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’. Annals of Oncology, 28 (12). pp. 3000-3008. ISSN 0923-7534

Marina, NM, Smeland, S, Bielack, SS et al. (50 more authors) (2016) Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncology, 17 (10). pp. 1396-1408. ISSN 1470-2045

This list was generated on Sun Mar 24 14:51:13 2024 GMT.